FI882380A - Synnerligen aktiva, lineaera och cykliska analoger av alfa-msh-fragment. - Google Patents

Synnerligen aktiva, lineaera och cykliska analoger av alfa-msh-fragment. Download PDF

Info

Publication number
FI882380A
FI882380A FI882380A FI882380A FI882380A FI 882380 A FI882380 A FI 882380A FI 882380 A FI882380 A FI 882380A FI 882380 A FI882380 A FI 882380A FI 882380 A FI882380 A FI 882380A
Authority
FI
Finland
Prior art keywords
msh
fragment
synnerligen
lineaera
cykliska
Prior art date
Application number
FI882380A
Other languages
English (en)
Finnish (fi)
Other versions
FI882380A0 (fi
Inventor
Victor J Hruby
Fahad A Al-Obeidi
Mac E Hadley
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of FI882380A0 publication Critical patent/FI882380A0/fi
Publication of FI882380A publication Critical patent/FI882380A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68Melanocyte-stimulating hormone [MSH]
    • C07K14/685Alpha-melanotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Steroid Compounds (AREA)
FI882380A 1987-05-22 1988-05-20 Synnerligen aktiva, lineaera och cykliska analoger av alfa-msh-fragment. FI882380A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5322987A 1987-05-22 1987-05-22
CA000578920A CA1340107C (en) 1987-05-22 1988-09-30 Linear and cyclic analoques of alpha-msh fragments with extraordinary potency

Publications (2)

Publication Number Publication Date
FI882380A0 FI882380A0 (fi) 1988-05-20
FI882380A true FI882380A (fi) 1988-11-23

Family

ID=25672150

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882380A FI882380A (fi) 1987-05-22 1988-05-20 Synnerligen aktiva, lineaera och cykliska analoger av alfa-msh-fragment.

Country Status (11)

Country Link
EP (1) EP0292291B1 (pt)
JP (1) JPH0826077B2 (pt)
CN (1) CN1031242C (pt)
AT (1) ATE109793T1 (pt)
CA (1) CA1340107C (pt)
DE (1) DE3851002T2 (pt)
DK (1) DK172760B1 (pt)
FI (1) FI882380A (pt)
IE (1) IE64903B1 (pt)
PH (1) PH25819A (pt)
PT (1) PT87560B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
US5683981A (en) * 1987-05-22 1997-11-04 Competitive Technologies, Inc. Cyclic bridged analogs of α-MSH and methods thereof
EP0389950A1 (en) * 1989-03-23 1990-10-03 Lion Corporation Melanocyte-stimulating hormone inhibitor and external preparation containing the same
US5071583A (en) * 1990-08-14 1991-12-10 Steve Martell Soap bar having a fifth finger gripping member
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5364851A (en) * 1991-06-14 1994-11-15 International Synthecon, Llc Conformationally restricted biologically active peptides, methods for their production and uses thereof
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
WO1994022460A1 (en) * 1993-04-05 1994-10-13 University Patents, Inc. Diagnosis and treatment of erectile dysfunction
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5420109A (en) 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
CA2368431C (en) 1999-03-29 2006-01-24 The Procter & Gamble Company Melanocortin receptor ligands
TW200716979A (en) * 1999-06-29 2007-05-01 Univ New York Screening methods for compounds that affect melanogenesis
DE10228837B4 (de) * 2002-06-27 2016-01-07 Elfriede Rauch Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
AU2004275928B2 (en) 2003-09-30 2010-03-11 Novo Nordisk A/S Melanocortin receptor agonists
EP2939686A1 (en) * 2004-10-08 2015-11-04 Clinuvel Pharmaceuticals Limited Compositions and methods for inducing melanogenesis in a subject
CN100355776C (zh) * 2005-06-20 2007-12-19 中国人民解放军第二军医大学 一种新型α-黑素细胞刺激素类似物及其用途
CN101528250A (zh) 2005-07-08 2009-09-09 研究及应用科学协会股份有限公司 黑皮质素受体的配体
DK2957292T3 (en) 2008-03-27 2018-01-22 Clinuvel Pharmaceuticals Ltd VITILIGOTERAPHY
NZ590254A (en) 2008-06-09 2012-07-27 Palatin Technologies Inc Melanocortin receptor-specific cyclic peptides for treatment of sexual dysfunction
WO2010022249A2 (en) 2008-08-20 2010-02-25 Ensemble Discovery Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
EP2504351A4 (en) 2009-11-23 2013-10-30 Palatin Technologies Inc MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
CN102725305B (zh) 2009-11-23 2016-08-24 帕拉丁科技公司 黑皮质素-1受体特异性环肽
CN102816211B (zh) * 2012-09-10 2014-07-23 南京工业大学 一种制备美那诺坦的方法
EP2970388B1 (en) * 2013-03-15 2018-07-25 Rhythm Pharmaceuticals, Inc. Peptide compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US448539A (en) 1891-03-17 Cornelius s morris
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin

Also Published As

Publication number Publication date
DK277788A (da) 1988-11-23
DE3851002D1 (de) 1994-09-15
IE881537L (en) 1988-11-22
EP0292291A3 (en) 1990-05-02
PT87560B (pt) 1992-09-30
CN1032795A (zh) 1989-05-10
AU1650688A (en) 1988-11-24
EP0292291B1 (en) 1994-08-10
EP0292291A2 (en) 1988-11-23
DK277788D0 (da) 1988-05-20
PH25819A (en) 1991-11-05
FI882380A0 (fi) 1988-05-20
AU618733B2 (en) 1992-01-09
PT87560A (pt) 1989-05-31
JPH0826077B2 (ja) 1996-03-13
JPS6470499A (en) 1989-03-15
CA1340107C (en) 1998-10-27
CN1031242C (zh) 1996-03-13
DK172760B1 (da) 1999-06-28
ATE109793T1 (de) 1994-08-15
IE64903B1 (en) 1995-09-20
DE3851002T2 (de) 1995-02-02

Similar Documents

Publication Publication Date Title
FI882380A0 (fi) Synnerligen aktiva, lineaera och cykliska analoger av alfa-msh-fragment.
KR860004920A (ko) 뉴클레오시드 및 이의 제조방법
KR880700670A (ko) 알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물
IT8423243A0 (it) Sci ottenuti per iniezione eprocedimento di fabbricazione di essi.
DE3784447D1 (de) Haertbare organopolysiloxanzusammensetzung.
DE68929551D1 (de) Menschliche DNase
DK203787D0 (da) Praeparat til nasal administrering
DE3674593D1 (de) Medizinische zusammensetzung.
DE3875300D1 (de) Turbo-verbundmaschine.
DE3781182D1 (de) Tamoxifen zur topischen verwendung.
DK49488D0 (da) Anaestesi-praeparat
FI881470A (fi) Cycliska peptider och deras framstaellning.
ES2036526T3 (es) Composiciones de interferon.
DK67683D0 (da) Fremgangsmade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
FI854074A0 (fi) Peptid-substituerade heterocykliska immunostimulanter.
FR2622103B1 (fr) Nouvelles compositions dermatologiques bronzantes insectifuges
DE3679947D1 (de) Halbleiteranordnungen und verfahren zur herstellung mittels ionenimplantation.
DE3751867D1 (de) Verstärker in Kaskodeschaltung
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
KR860005098A (ko) 지반경화 안정처리 공법
DE3879709D1 (de) Platin-arzneimittel.
MY104115A (en) Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
IT1203543B (it) Composizioni per iniezione stabilizzate e loro preparazioni
DE3862347D1 (de) Substituierte anthrachinone und haertbare zusammensetzung.
BR6702948U (pt) Seringa triplice odontologica

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: UNIVERSITY PATENTS, INC.